This site is intended for UK healthcare professionals
Medscape UK Univadis Logo
Medscape UK Univadis Logo
Clinical Summary

Quitting Smoking Boosts Life Expectancy at Any Age

TOPLINE:

Quitting smoking at any age increases life expectancy, with the most significant increases observed in younger individuals. But people who quit over age 65 can extend life expectancy. 

METHODOLOGY:

  • Researchers analyzed the detrimental effects of smoking and the positive impacts of cessation on life expectancy in individuals aged 35-75 years.
  • Age-specific death rates by smoking status were calculated using the relative risks for all-cause mortality derived from the Cancer Prevention Study II data, 2018 National Health Interview Survey smoking prevalence data, and 2018 all-cause mortality rates.
  • Life tables were constructed to obtain information on the life expectancies of people who never smoked, those who currently smoked, and those who previously smoked but quit at various ages.
  • Estimates of years lost due to smoking and years gained by quitting smoking were calculated for people starting at age 35 and over 10-year increments.

TAKEAWAY:

  • Compared with people who never smoked, those who smoked at ages 35, 45, 55, 65, and 75 years and continued smoking throughout their lives would lose 9.1, 8.3, 7.3, 5.9, and 4.4 years, respectively.
  • People who quit smoking at ages 35, 45, 55, 65, and 75 years would have life expectancies that are shorter by 1.2, 2.7, 3.9, 4.2, and 3.7 years, respectively, than those of same-age individuals who never smoked.
  • Individuals who quit smoking at ages 35, 45, 55, 65, and 75 years would experience an additional 8.0, 5.6, 3.4, 1.7, and 0.7 years of life expectancy compared with those who continued smoking.
  • People who quit at ages 65 and 75 years would have a 23.4% and 14.2% chance of gaining at least 1 additional year of life.

IN PRACTICE:

"This cessation benefit is not limited to young- and middle-aged adults who smoke; this study demonstrates its applicability to seniors as well. These findings may be valuable for clinicians seeking scientific evidence to motivate their patients who smoke to quit," the authors wrote.

SOURCE:

The study was led by Thuy T.T. Le, PhD, from the Department of Health Management and Policy at the University of Michigan School of Public Health in Ann Arbor and published online on June 25 in the American Journal of Preventive Medicine.

LIMITATIONS:

The study's estimates were according to data from 2018 and may not reflect current trends. The estimates also did not account for variability in smoking intensity among individuals.

DISCLOSURES:

The study was supported by grants from the National Cancer Institute of the US National Institutes of Health and the US Food and Drug Administration Center for Tobacco Products. The authors declared that they had no conflicts of interest.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

YOU MAY ALSO LIKE

Streeting has faced criticism from within his own party for the decision.
Tisotumab vedotin reduced the risk of dying by 30% in this phase 3 trial.
Hospitalisations and deaths did not decline over the course of a decade.
In the first of a series on the impact of sex-specific factors on CVD, Dr Shrilla Banerjee and Dr F Aaysha Cader outline how differences in risk between men and women should be reflected in guidance
Opioid overdose rates rose in seniors; less than half received necessary treatment. Clinicians can focus on safer pain management and reducing addiction risks via screening and patient-centered care.
Severe shortness of breath and night sweats in a 48-year-old man was diagnosed as ‘crack lung’ due to cocaine use.
Incisions have become smaller and less invasive over time, according to one gynecologist.
An AI-enabled system of wearable coils and ingestible "smart" pills shows promise for identifying and tracking gasses in the GI tract associated with digestive disorders.
Valerie Benfield, Head of Events, answers the Guidelines in Practice Team's questions about the Management Stream at Guidelines Live—a brand new stream for the 2024 event
Experts are optimistic that image analysis, natural language processing, and generative AI will soon become foundational to the management of patients with IBD.
There's a range of options available for healthcare professionals to offer people when a flutter during a summer of sport turns into more serious gambling problems.
Boosting levels with diet and supplements reduced numbers of skin lesions and improved quality of life.
Depressed parent symptoms track together and ultimately lead to depression in teenage offspring.
Around 9000 patients in England currently receiving ocrelizumab infusions will switch to the new 10-minute injection, thanks to the NHS rollout.
A proposed major shift from a clinical definition of Parkinson's disease to the one based on biology has triggered debate among experts in the field.
Faltering economic growth means the UK has less money to spend on health than some of its European neighbours. Can it catch up?
Digital technologies are being developed to objectively measure indicators of a disease and treatment response. But will they reach clinical practice?
In an alarming case, a Brazilian doctor received 1300 messages from a stalker in a single day.
Positive results from the DanGer Shock trial were expected to alter the course of competing studies of the world's smallest heart pump, and for RECOVER IV, the trial is terminated.
Many doctors and their organizations spoke out against the far right during the recent elections, but their political clout may be less than is imagined.